Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Myriad Genetics (MYGN) Receivables - Other (2016 - 2021)

Myriad Genetics has reported Receivables - Other over the past 12 years, most recently at $2.4 million for Q1 2021.

  • Quarterly Receivables - Other fell 4.0% to $2.4 million in Q1 2021 from the year-ago period, while the trailing twelve-month figure was $2.4 million through Mar 2021, down 4.0% year-over-year, with the annual reading at $2.0 million for FY2020, N/A changed from the prior year.
  • Receivables - Other was $2.4 million for Q1 2021 at Myriad Genetics, up from $2.0 million in the prior quarter.
  • Over five years, Receivables - Other peaked at $6.9 million in Q3 2017 and troughed at $2.0 million in Q3 2020.
  • The 5-year median for Receivables - Other is $4.3 million (2018), against an average of $4.1 million.
  • Year-over-year, Receivables - Other surged 72.73% in 2017 and then tumbled 58.33% in 2020.
  • A 5-year view of Receivables - Other shows it stood at $6.0 million in 2017, then decreased by 1.67% to $5.9 million in 2018, then plummeted by 40.68% to $3.5 million in 2019, then crashed by 42.86% to $2.0 million in 2020, then increased by 20.0% to $2.4 million in 2021.
  • Per Business Quant, the three most recent readings for MYGN's Receivables - Other are $2.4 million (Q1 2021), $2.0 million (Q4 2020), and $2.0 million (Q3 2020).